CLIMB BIO INC (CLYM) Stock Balance Sheet
USA - NASDAQ:CLYM - US28658R1068 - Common Stock
1.935 USD
+0.04 (+1.84%)
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 25.80M | 87.23M | 93.11M | 43.60M | 46.90M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 61.10M | 63.69M | 13.69M | 80.00M | 89.60M | |||
| Receivables | null | 1.12M | null | null | null | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 4.06M | 2.83M | 3.46M | 10.90M | 11.80M | |||
| Total Current Assets | 90.96M | 154.87M | 110.25M | 134.40M | 148.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 880.00K | 490.00K | 199.00K | 500.00K | null | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | 90.46M | 61.83M | 15.00K | 100.00K | 25.00M | |||
| Total Non-Current Assets | 91.34M | 62.31M | 214.00K | 600.00K | 24.90M | |||
| TOTAL ASSETS | 182.30M | 217.19M | 110.47M | 135.00M | 173.20M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | null | null | null | null | null | |||
| Accrued Expenses | 4.47M | 4.20M | 2.77M | 5.30M | 4.60M | |||
| Accounts Payable | 477.00K | 705.00K | 66.00K | 800.00K | 1.40M | |||
| Other Current Liabilities | null | 31.00K | null | 0 | 0 | |||
| Total Current Liabilities | 4.95M | 4.93M | 2.83M | 6.10M | 6.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 352.00K | 375.00K | 37.00K | 200.00K | null | |||
| Total Non-Current Liabilities | 352.00K | 375.00K | 37.00K | 200.00K | 0 | |||
| TOTAL LIABILITIES | 5.30M | 5.31M | 2.87M | 6.30M | 6.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -272.21M | -229.88M | -155.98M | -120.90M | -75.60M | |||
| Additional Paid In Capital | 448.74M | 441.73M | 263.58M | 249.90M | 242.90M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 7.00K | 7.00K | 3.00K | 0 | 0 | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | 469.00K | 23.00K | -2.00K | -400.00K | -100.00K | |||
| Shares Outstanding | 68.18M | 67.26M | 27.70M | 26.60M | 26.20M | |||
| Tangible Book Value per Share | 2.5959 | 3.1504 | 3.8845 | 4.8383 | 6.3817 | |||
| Total Shareholders' Equity | 177.00M | 211.88M | 107.60M | 128.70M | 167.20M | |||
| TOTAL LIABILITIES AND EQUITY | 182.30M | 217.19M | 110.47M | 135.00M | 173.20M | |||
| Statistics | ||||||||
| Current Ratio | 18.38 | 31.41 | 38.92 | 22.03 | 24.72 | |||
| Return On Assets (ROA) | -27.84% | -34.02% | -31.79% | -33.51% | -30.04% | |||
| Return On Equity (ROE) | -28.67% | -34.88% | -32.64% | -35.15% | -31.12% | |||
All data in USD , ROIC based on taxRate of 0.21